In the BioHarmony Drug Report Database

"Preview" Icon

Flecainide

Tambocor (flecainide) is a small molecule pharmaceutical. Flecainide was first approved as Tambocor on 1985-10-31. It is used to treat atrial fibrillation, cardiac arrhythmias, supraventricular tachycardia, and ventricular tachycardia in the USA. It is known to target potassium voltage-gated channel subfamily A member 7, potassium voltage-gated channel subfamily A member 1, potassium voltage-gated channel subfamily A member 5, potassium voltage-gated channel subfamily C member 1, and potassium voltage-gated channel subfamily A member 2.

 

Trade Name

 

Tambocor
 

Common Name

 

flecainide
 

ChEMBL ID

 

CHEMBL652
 

Indication

 

atrial fibrillation, cardiac arrhythmias, supraventricular tachycardia, ventricular tachycardia
 

Drug Class

 

Ic antiarrhythmic

Image (chem structure or protein)

Flecainide structure rendering